Is it standard to place a nephrostomy (percutaneous catheter) tube in patients with ureteral (urine flow) stents?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 18, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Nephrostomy Tubes Are NOT Standard When Ureteral Stents Are Successfully Placed

No, it is not standard practice to place nephrostomy tubes when ureteral stents are successfully placed. These are alternative drainage methods, not complementary procedures, and the choice between them depends on clinical circumstances and technical feasibility.

Standard Approach: Stents vs Nephrostomy Tubes

Primary Drainage Strategy

  • Ureteral stents and nephrostomy tubes serve as alternative methods for urinary drainage, not concurrent procedures 1.

  • In the majority of cases, a ureteral stent can be placed either via the bladder (retrograde) or via the kidney (antegrade), and this is typically the preferred approach when technically feasible 1.

  • Nephrostomy tubes are reserved for situations where ureteral stenting fails or is not possible 1, 2.

When Nephrostomy Is Used Instead of Stenting

  • Percutaneous nephrostomy should be performed when stent placement is unsuccessful or not possible 1, 2.

  • Specific scenarios requiring nephrostomy include:

    • Complete ureteral transection where the proximal ureter cannot be cannulated in a retrograde fashion 1
    • Patient instability that precludes attempts at retrograde stent placement 1
    • Failed retrograde ureteral access despite multiple attempts 2
    • Damage control situations where immediate repair is not feasible, requiring temporary ureteral ligation with nephrostomy placement followed by delayed reconstruction 1, 2

Special Circumstances: Combined or Sequential Approaches

Antegrade Stenting After Initial Nephrostomy

  • In some cases, nephrostomy is placed first, and then a ureteral stent is subsequently placed through the nephrostomy tract (antegrade approach) 1.

  • "Rendez-vous" techniques or even one-step antegrade stent placement (without leaving the nephrostomy as a safety measure) can yield successful alternative approaches 1.

  • This sequential approach is used when retrograde access is not possible, such as with large impacted upper ureteral stones, after urinary diversion, or when retrograde access has failed 2.

When Both May Be Temporarily Present

  • If nephrostomy alone does not adequately control a urine leak after ureteral injury, options include placement of a periureteral drain or immediate open repair—not routine dual drainage 1.

  • In malignant obstruction cases where single stents fail, placement of two parallel ipsilateral ureteral stents may obviate the need for nephrostomy tube placement 3.

Clinical Decision-Making Algorithm

For Ureteral Obstruction Management

  1. First-line approach: Attempt retrograde ureteral stent placement 2, 4
  2. If retrograde stenting fails: Place percutaneous nephrostomy 1, 2
  3. After nephrostomy placement: Consider subsequent antegrade stent placement if appropriate 1
  4. Remove nephrostomy once stent is functioning: The nephrostomy is not maintained alongside a functioning stent 1

For Ureteral Trauma

  • Incomplete injuries: Attempt stent placement first; if unsuccessful, proceed to nephrostomy with delayed repair 1, 2
  • Complete transections requiring repair: Primary repair over a ureteral stent (not with concurrent nephrostomy) 1, 2
  • Damage control scenarios: Ureteral ligation with nephrostomy, followed by delayed definitive repair with stenting 1, 2

Common Pitfalls to Avoid

  • Do not routinely place nephrostomy tubes alongside successfully functioning ureteral stents—this adds unnecessary morbidity and external drainage burden 1.

  • Do not persist with failed retrograde stenting attempts when nephrostomy is clearly indicated—this delays appropriate drainage and risks complications 1, 2.

  • Failing to recognize that in malignant obstruction, internal ureteral stents have a higher failure rate (11%) compared to nephrostomy tubes (1.3%), requiring closer monitoring for ongoing obstruction 4.

  • Underestimating that nephrostomy tubes have their own complications, including a 6-15% complication rate and frequent need for rehospitalization, making successful stenting preferable when feasible 1, 4, 5.

Related Questions

What is the best management for a patient with stage 4 prostate cancer, bilateral orchiectomy, left hydronephrosis, impaired renal function, and elevated PSA?
What is the best next step in managing a 24-year-old primigravida (first pregnancy) at 26 weeks gestation with symptoms of urinary frequency, back pain, and a history of nephrolithiasis (kidney stones), presenting with normal fetal movement, mild hypertension, and impaired renal function, as evidenced by bilateral renal enlargement and dilation of the renal pelvis and proximal ureter on ultrasound?
What is the best management for a 78-year-old man with stage 4 adenocarcinoma (cancer) of the prostate, presenting with marked left hydronephrosis (kidney swelling) and impaired renal function (elevated serum creatinine), despite being asymptomatic?
Do ureteral stents need to be exchanged in cases of percutaneous nephrostomy (PCN) related infections?
What is the next step in managing a 42-year-old woman with abdominal pain, a non-contrast computed tomography (CT) scan showing a retroperitoneal mass encasing the aorta and inferior vena cava, impaired renal function (elevated serum creatinine), and hyperkalemia (elevated serum potassium), with no evidence of malignancy on percutaneous biopsy?
What dosage of piperacillin-tazobactam is recommended for a patient with a creatinine clearance of 115, interstitial lung disease, and an infection?
What is the recommended treatment for a 69-year-old healthy woman with Herpes Simplex Virus type 2 (HSV-2) on her buttocks, considering valacyclovir (Valtrex) or acyclovir?
What is the initial treatment approach for an adult patient with hypertension?
Is topical treatment necessary for a 69-year-old healthy woman with Herpes Simplex Virus type 2 (HSV-2) on her buttocks who is already taking valacyclovir (valacyclovir)?
What is the recommended administration schedule for the DTPa (Diphtheria, Tetanus, and Pertussis) vaccine?
What is the role of tolvaptan (vasopressin receptor antagonist) in treating patients with heart failure and dilutional hyponatremia?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.